Available on the DxH 690T, the Early Sepsis Indicator is the only FDA-cleared hematologic biomarker specifically for aiding in the early diagnosis of sepsis BREA, Calif., May 18, 2020 /PRNewswire/ -- ...

Benefit from accurate and comprehensive analysis in your low-volume lab setting. The DxH 500 hematology analyzer can help you improve clinical decision-making and efficiency. Built on proven cellular ...

Beckman Coulter , a global leader in clinical diagnostics, today announced the commercial launch of its new DxH 690T hematology analyzer. Designed to help laboratories streamline workflow and maximize ...

The technology is superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making The DxH 690T's automated capabilites are a significant ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The US Food and Drug Administration (FDA) today announced a Class 1 recall of Beckman Coulter DxH 800, DxH 600, and DxH 900 hematology analyzers after complaints of inaccurate platelet counts. The ...

Beckman Coulter Inc., the Fullerton maker of medical diagnostic equipment and supplies, got a positive review by a Lazard Capital Markets analyst for its blood analyzer and its effort at a major ...